MedPath

Treatment of Neurocysticercosis in children with Albendazole Should it be 1 or 4 weeks

Phase 4
Completed
Conditions
Health Condition 1: null- Patients with seizures and on CT scan of Head having Single small enhancing lesion
Registration Number
CTRI/2010/091/000045
Lead Sponsor
Dr Praveena Dhiman
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
120
Inclusion Criteria

Children up to 12 years of age with seizures and CECT head having-
*Single small <20 mm enhancing wel defined lesion with regullar outline
*Edema of surrounding area may or not be present
*Presence of contrast enhancement - ring or disc type
*No midline shift, no mass effect

Exclusion Criteria

*Children with multiple lesions on CT head
*Children with neurological deficit
*Children with suspected Tuberculosis and Mantoux positive
*Children who have already got cysticidal therapy
* Unstable and critically ill children

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Resolution of single small enhancing CT lesionTimepoint: 6 months
Secondary Outcome Measures
NameTimeMethod
Seizure recurrenceTimepoint: 6 months
© Copyright 2025. All Rights Reserved by MedPath